Human papillomavirus vaccines. WHO position paper
Wkly Epidemiol Rec. 2009 Apr 10;84(15):118-31.
[Article in
English,
French]
No abstract available
MeSH terms
-
Condylomata Acuminata / prevention & control
-
Cost-Benefit Analysis
-
Female
-
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
-
Humans
-
Male
-
Papillomaviridae / immunology
-
Papillomavirus Infections / economics
-
Papillomavirus Infections / epidemiology
-
Papillomavirus Infections / prevention & control
-
Papillomavirus Vaccines / administration & dosage
-
Papillomavirus Vaccines / economics
-
Papillomavirus Vaccines / immunology
-
Papillomavirus Vaccines / therapeutic use*
-
World Health Organization*
Substances
-
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
-
Papillomavirus Vaccines